Navigation Links
GenePaint from Tecan

ProductsGenePaint from Tecan
Company Tecan
Item GenePaint
Description Tecans GenePaint system, which is based on a new flow-through technology, automates all of the steps required for performing in situ hybridization of tissues on microscope slide formats.

A key step in the study of gene expression, in situ hybridization (ISH) localizes transcripts in intact cells and tissues and can be used to validate and confirm results obtained by in vitro gene expression methods (microarrays, blots, etc.). GenePaint automates the processing of large numbers of cell or tissue samples in these type of procedures; an otherwise extremely time consuming and laborious manual process.

Advanced features for functional genomic studies include:
  • eliminates 80% of the manual steps of conventional ISH, FISH or IHC analysis
  • extends walk-away time through unattended hybridization protocols
  • allows the use of any commercial set of reagents for hybridization studies
  • assures consistent and reproducible results of excellent quality
  • saves on the amounts of reagents used
  • The applications described here are not available in the US outside of the research market.
    Info TecanTecan
    Tecan U.S., Inc.
    4022 Stirrup Creek Road
    Suite 310
    Durham, NC 27703

    Customer Service: (800) 338-3226
    Fax Number: (919) 361-5201
    Web Site:
    NOTE: Price information is approximate list price and actual prices may vary.

    Related biology products :

    1. Connect from Tecan
    2. Freedom EVOlyzer from Tecan
    3. ELISA Biopharma from Tecan
    4. HS 4800 Hybridization Station from Tecan
    5. HS 400 Hybridization Station from Tecan
    6. Freedom EVO Clinical from Tecan
    7. Freedom EVO 150 from Tecan
    8. TRAC Tecan Robotic Assay Composer from Tecan
    9. Aquarius 384 Multichannel Pipettor from Tecan
    10. Freedom EVOware from Tecan
    11. Columbus from Tecan
    ... bis- (3-D-Gluconamidopropyl)deoxycholamide White solid. HYGROSCOPIC. ... CHAPSO. Has reduced electrostatic interactions that do ... DEAE-cellulose. Aggregation number: 8-16. Purity: ≥95% ... O. Aggregation number 8 - 16, CMC ...
    Goat Anti-Horse IgG(T) Antibody, Unconjugated...
    Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
    Mouse monoclonal antibody to RNase L...
    Biology Products:
    (Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: ... banks to provide their customers enhanced security to ...
    (Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
    (Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
    Breaking Biology News(10 mins):
    (Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
    (Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
    (Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
    (Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
    Breaking Biology Technology: